Background The toxic oil syndrome (TOS) Women <40 years old, who were affected by TOS , were at greater risk for death in most time periods than their unaffected peers, while older women and men were not. Over the follow-up period, mortality of the cohort was less than expected when compared with mortality of the general Spanish population, or with mortality of the population of the 14 provinces where the epidemic occurred. We also found that, except for deaths attributed to external causes including TOS and deaths due to pulmonary hypertension, all causes of death were decreased in TOS patients compared to the Spanish population. The most frequent underlying causes of death were TOS, 350 (21.1%); circulatory disorders, 536 (32.3%); and malignancies, 310 (18.7%). Conclusions We conclude that while on average people affected by toxic oil syndrome are not at greater risk for death over the 13-year study period than any of the comparison groups, women <40 years old were at greater risk of death.
The toxic oil syndrome (TOS) epidemic, which began in Madrid, then continued through northwest Spain, occurred in 1981, arose as a result of people consuming an oil fraudulently sold as pure olive oil, but which was instead rapeseed oil that had been denatured with aniline for industrial use and subsequently refined. 1 " 4 The epidemic produced approximately 20 000 cases of a new illness characterized by an acute phase with pulmonary symptoms suggestive of an atypical pneumonia, including cough, dyspnoea, and infiltrates on chest roentgenogram. At least half of the patients developed an intermediate phase characterized by eosinophilia, myalgia, weight loss, hepatopathy, alterations in superficial and deep sensation, and pulmonary hypertension. In most patients the intermediate phase evolved into the chronic phase of TOS, with development of peripheral neuropathy, hepatopathy, sclerodermiform skin changes, and pulmonary hypertension. 2 " 5 Previous reports suggest that about 300 deaths attributed to TOS were documented in the 2 years following the epidemic. 5 ' 6 Clinically the causes of death changed during the first months after the initial onset of the disease from respiratory failure due to non-cardiogenic interstitial oedema to severe neuromuscular deficit, thrombosis of large vessels, and primary pulmonary hypertension. However, since the first 2 years in which the deaths of TOS patients were clearly linked with the disease, a dear relationship between causes of death and TOS has not been established except among those patients who have developed pulmonary hypertension. Initially, TOS mortality data was not collected systematically; instead, reports of deaths associated with TOS were obtained through passive reporting. In 1986 a comprehensive list of all TOS affeaed people whose deaths had been recorded by any of the TOS administrative offices was compiled. Review of this information suggested a substantial underascertainment of deaths (unpublished data Instituto de Salud Carlos m-1987).
Because TOS is a previously unknown disease that has led to substantial morbidity in the chronic phase and an apparently high mortality rate in the first 2 years, we believe that it is imperative to ascertain the trends in the mortality of the cohort over time. 7 The objective of this study is to learn about the course of the disease through the analysis of the evolution of mortality and its causes in TOS patients over 13 years, using methods previously validated in the pilot study.
Methods

Study population
The urgent medical needs of the population at the onset of the epidemic hindered the development of a TOS patient registry specifically designed to collect data for scientific analysis. Once the early part of the epidemic had passed, a list of patients, called the official census, was developed in 1981 for administrative purposes, however, it did not use systematic inclusion criteria for cases of TOS. This census was based on lists of patients diagnosed with TOS who had been seen in any of the clinical centres of the Spanish National Institute of Health medical system, INSALUD, which provides health care coverage to 100% of residents of Spain. The 1981 census contained over 15 000 entries. With time this number increased as patients who did not require urgent treatment when the epidemic began were diagnosed, and by 1985 the census contained 20 643 entries. The 1985 census data is considered to be much more comprehensive than the 1981 data, and was the first available to us in a computerized format, thus we considered all 20 643 people registered in the Spanish government's 1985 official census of people affeaed by TOS, which we will refer to as the official census (OC), eligible for inclusion in this study.
The OC information used here is the same as was used in our 1988 pilot study, which was done to determine mortality in a systematic 5% random sample. 6 For the pilot study, the OC was sorted on gender, age, and geographical location, then every 20 th record was sampled starting at a randomly chosen point. That study showed the feasibility and validity of a direa contaa, through a mailed questionnaire or a telephone call, to assess the vital status (living or dead) of the sample.
We knew from the pilot study 6 that errors existed in the OC. Thus, before we determined the study population, we assembled information from unpublished work that had reviewed the clinical histories of TOS patients, and crossed this data by census number and name with the data in the OC. After thorough investigation we excluded 535 duplicate records and 12 records that had clearly resulted from data entry errors in the 1985 OC. We were unable to locate people corresponding to 342 (1.7%) of the OC records, in spite of exhaustive attempts to do so. Upon review, these 342 records were found to be very incomplete, lacking specific idenrifying information, such as a complete name, date of birth, hospital where treated, address, or phone number. Of the 342 records, 336 were attributed to the Madrid province. Since Madrid was where the epidemic began and where the majority of affeaed patients lived, we believe that the emergent circumstances under which many patients were treated during the early moments of the epidemic may have led to the creation of erroneous patient records. No other specific localizing information could be found for the names listed on these records, using the OC and other sources of information. In addition, the health centres responsible for these 342 records had no evidence to suggest that the people named on these records had ever been registered as patients in INSALUD. The study population thus consisted of 19 754 patients or patient proxies, such as a spouse, parent, sibling, or other relative, who were successfully located and contaaed either by mail or by telephone.
Data collection
Our method for collection of death data has been detailed previously. 6 Briefly, we mailed a packet including a cover letter, a two-page questionnaire, and a postage-paid retum-addressed envelope to each person registered in the OC for whom an address was available. The questionnaire requested general identifying information on the person to whom the letter was addressed, such as name, address, phone number, national identity document number (DN1), the name and contaa information for a family member who could be contaaed if necessary, information on the vital status of that person, and in the event that the addressee had died, a proxy was asked to give the date and place of death. In the first mailing, the families of TOS patients who were already known to have died were also mailed a questionnaire with a different cover letter requesting the date and location of the deceased's death in addition to the same information requested from all other participants. If no address was available, the letter was returned as undeliverable, or an alternate address could not be found, or if no response was obtained within 6 weeks, telephone contaa was attempted. This was done by direa calls if a telephone number for the name of the patient or a dose relative was found. A few TOS patients or their families were located with the cooperation of neighbours, munitipal authorities, and local police. Questionnaire data from the first contaa were transcribed by a professional data transcription service with established quality control measures that give a data entry error rate of 1 error per 6000 keystrokes.
Each subjea or proxy induded in the study has been contaaed three times. The first contaa was between February 1992 and February 1994 and used the above methods. The second contact took place between July 1994 and July 1995, and the third contact between July 1995 and July 1996. In the second and third contacts, proxies were contacted only by telephone for those found to have died from data obtained in the first or second mailing. The second and third contacts were intended primarily to uncover new deaths, and to maintain the contact information as current as possible. Data from the second and third contacts were entered by in-house personnel, using a system with internal self-checking mechanisms which strictly limited changes to the database, in order to minimize data entry errors.
Deaths were validated by obtaining death certificates. Spanish law requires that each town maintain a civil registry of death, birth, and marriage certificates. Using the information on names, addresses, and date and place of death which we collected, we requested death certificate information from the appropriate civil registries. After all cause of death data was collected from death certificates, coding of the underlying causes of death using the International Classification of Diseases 9th Revision (ICD-9) was performed in Madrid at the Servicio de Informaci6n Sanitaria de la Consejeria de Salud de la Comunidad Autonoma de Madrid, by experienced nosologists who code over 200 000 death certificates annually for the community of Madrid. After review of each death certificate, the nosologist determined the underlying cause of death. From 1989 onwards Spanish law adopted the internationally accepted format for use of three causes of death, in which case the nosologist determined the underlying cause of death from the causes listed. These were then reviewed and categorized using the first three digits of the ICD-9 code.
We selected a random sample of 1000 names from the OC of people who resided in the Madrid province in 1996 to validate that people listed as living in our database were, in fact, alive. The DNI of these names were cross-checked against the DNI in the Madrid death registry, and no matches were found. To further establish that these people were not in the death registry, we matched the two databases by surname and date of birth within 6 months. Although some rough matches were found, when information such as sex, first name, and other data were compared, no true matching records were located.
Data were collected and analysed for deaths which occurred from 1 May 1981, the date when the epidemic began, through 31 December 1994. The numbers of deaths were tabulated for each calendar year from 1982 through 1994, and for the period 1 May through 31 December 1981.
Statistical methods
We calculated the standardized mortality ratio (SMR) for each period or calendar year and a 95% confidence interval (CI) for the SMR using Byar's approximate method. 8 We estimated two sets of SMR; one was calculated for the whole cohort and used as a standard for the population of Spain, the second was calculated using the population of the 14 provinces where 99.7% of the study population lived (60 (0.3%) people living in other provinces were excluded).
The yearly mortality rates of the cohort were also calculated and standardized to the age and sex composition of the Spanish population for each period using the direct method based on a person's age on 31 December of each year. 8 We calculated both SMR and directly adjusted rates on the basis of the risk for each age and sex stratum. (Tables 1 and 2 respectively). Two people are excluded from Tables 1 and 2 , one for whom the date of birth is not known and another for whom the date of death is not known. In 1982, the SMR for total mortality was about 1, whereas a consistent deficit of deaths is seen for all but 2 years from 1983 onwards, corresponding to SMR of approximately 0.7-0.8. These SMR were not substantially affected by the reference population, that of Spain or of the 14 provinces, which was used.
The SMR for total deaths show a substantial excess mortality in women aged <40 in all years after the epidemic in 1981 (Table 3) . From 1983 through 1994, we found 62 deaths in this subcohort versus the 32 expected. Conversely, up to 1991, in women aged 40-59, SMR were dose to unity. In very young men the number of observed deaths was too small for any inference.
Mortality by cause
The SMR estimated on the basis of mortality rates in the Spanish population, for large categories of causes of death, are given separately for the periods 1981-1982 and 1983-1994 (Table 4) . Eight death certificates could not be obtained, and these deaths are not induded in the analysis by cause. Of the 409 deaths from external agents (ICD-9 800-999), the death certificates for 350 indicated TOS as the underlying cause of death; in the periods 1981-1982, 1983-1985, 1986-1988, 1989-1991, and 1992-1994, 228, 60, 21, 20 , and 21 deaths were attributed to TOS respectively.
The most frequent cause of death in the TOS cohort is the category which indudes TOS, although deaths from cardiovascular and pulmonary diseases, injuries, and malignandes are frequent (Table 5) . No specific cause of death has been shown to be more frequent in the TOS cohort than in the Spanish population, with the exceptions of TOS and pulmonary hypertension. Three deaths from pulmonary hypertension (ICD-9 416.0) were found in the cohort during the study period (SMR = 18.15, 95% CI: 3.65-53.02).
Discussion
The objective of this study, to learn about the causes and evolution of mortality in TOS patients, has two pertinent facets: Compared with the rate in the Spanish national population for each year c Standardized mortality ratio (95% confidence interval). (1) it gives us information about the most relevant outcome of severity of the disease. However, in the case of TOS we find a cohort of sick people, death, while deriving new causal hypotheses, and (2) it allows us to analyse other potentially fatal outcomes of TOS, such as cancer, without having to use a cancer registry that includes a TOS and non-TOS population. To date, although we have not had a sufficient survival time to evaluate whether or not cancer was one of the terminal events of this intoxication, the findings regarding cancer have not been alarming.
Mortality studies can yield more information when the risk of death is analysed with respect to variables which indicate ourselves with the problem of the lack of a strict definition of severity from the prognostic aspect. Also, during the first years of the epidemic, the information collected was not conducive to construction of an index which could measure severity. At present studies which are more clinically oriented are underway, and these will give us information about prognostic factors in relation to specific causes of death, such as pulmonary hypertension.
We found a statistically significant increase in mortality among patients with TOS compared with the Spanish population as a whole during 1981. In 1982 the SMR was also elevated, although it is not statistically significant. We were surprised to find that women aged <40 years exhibited an excess mortality which has persisted through 1994. In 1981, young women were particularly hard hit by TOS. 3 - 5 We believe that this could be because many women in this age group were not employed outside the home and ate most of their meals at home. Thus, these women might have consumed more of the toxic oil. Other risk factors could also play a role in explaining why these women had excess mortality. For example, HLA DR4 and HLA DQR 9 and being a slow acetylator 10 are factors in TOS patients which have been shown to be increased in women, and which may have increased the risk of developing TOS for women. Deaths may also be increased in young women as a result of pulmonary hypertension. A number of deaths for which the underlying cause on the death certificate is listed as TOS might have resulted from pulmonary hypertension due to TOS. We know that pulmonary hypertension is often found clinically in young women of the TOS cohort, and the three deaths from pulmonary hypertension which we found were all women. Studies are in progress to further evaluate the occurrence of pulmonary hypertension in the TOS cohort. While findings of the present study are likely to be relevant to the natural history of TOS, we believe that any hypotheses regarding the cause of the increased mortality in this age group should await the results of death certificate and medical record studies to validate the causes of death.
We also found a persistent decrease in overall mortality, from 1983 onward, confirming estimates from the pilot study. 6 This decrease holds true when the analysis is performed looking only at the 14 provinces, although for 1983, 1986, 1987, 1992, 1993 , and 1994 the 95% CI includes 1 ( Table 2 ). The overall decrease in mortality in the TOS cohort after 1982 can be attributed primarily to the decrease in mortality in males of most ages and in females aged 3*40 (Table 3) . We do not believe that the overall decrease in mortality is a result of data entry errors, as our data entry methods had extensive quality controls. People who died might be erroneously classified as alive through a data entry error, however, because the cohort has been surveyed three times, such an error would likely have been found. In order to ensure that deaths were not erroneously reported, we verified all but eight deaths by obtaining the death certificate, and these eight deaths were verified through examination of clinical records. Thus we believe that our three sequential surveys, the review of death certificates, the validation of a random sample of 1000 records in Madrid, and the obtention of clinical records all serve to establish that the death data is accurate.
We used both the general Spanish population and the population of the 14 provinces where most TOS cases occurred as comparison groups. While most mortality studies use the general population of the country as a comparison group, we decided to also use the population of the 14 provinces where TOS occurred as another comparison group, as we believe that the population of the 14 provinces may be more representative of the population which developed TOS. We found, however, that the mortality in the TOS cohort was lower than that of either of these two comparison groups. We also used a smaller comparison group, several local communities where the TOS rates were substantial, as comparison groups. With these communities for comparison, the SMR of the TOS group was closer to that of the comparison group (data not shown). Similar findings using comparison groups such as these have been seen in other studies.
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The total number of deaths in the category including TOS deaths was 230 during the first time period, far more than would be expected for the category, while for most other causes, the number of deaths is less than expected (Table 4) . If the TOS deaths were distributed in all the other categories of death, the SMR would be closer to 1, although the total deaths would still not reach the expected number for the cohort, based on the rate in the Spanish population.
We excluded 342 records, 336 of which were from Madrid, from the study population. If we were to assume that all 342 records represent dead people for whom no records could be located, we would also have to assume that they sought no medical treatment for their illnesses. Were this to be the case, they likely would have died during the first few months of the epidemic in 1981 when the census of cases was less well maintained. This would increase the SMR for 1981 in Madrid, but External causes (including E865-TOS) E800-E999 All other codes
External causes (excluding E865-T0S) E800-E999
' Standardized mortality ratio (95% confidence interval). the SMR for the other years and other provinces would remain low, a circumstance which we believe would be very unlikely. However, we do not believe that these 342 records represent real people; INSALUD had no additional information or records associated with these names. We know how the OC was set up, and we know that it contained many errors. Thus, we do not believe that these records represent cases of TOS; medical care in Spain is provided almost exclusively through INSALUD, and had these OC records represented real people, corresponding INSALUD clinical records would exist, but they do not. Additionally, we believe that our system for identifying deaths in the TOS cohort is not only specific, but also sensitive; the survey completed through December 1994 found no cases misdassified as alive before 1995 who were deceased.
1981-1982 period
Thus, we believe that the decrease in mortality which we see after 1982 is real and has several possible explanations. The decreased mortality could represent a 'healthy survivor' effect, that is, certain cohort members, who may have been chronically ill from other diseases as well, may have died prematurely as a result of TOS in 1981, thus selecting the fittest for survival. Interestingly, in 1981-1982 there were no excess deaths among the oldest, perhaps because TOS was less severe in this age group (possibly because of a lower consumption of oil). In addition, a 'healthy survivor effect', similar to the 'healthy worker effect' in occupational studies, 12 would tend to decrease with time; in the present study the mortality in the groups which were previously low approach an SMR of 1 in the most recent time period. Another explanation could be that people in the TOS cohort in general receive more medical care benefits than the average citizen; the role of the increased use of the health care system after 1981 is not known. Paradoxically, incapacitation may exert a protective effect, in the sense that people are less exposed to work-related illnesses, vehicle collisions, falls, and other injuries. The results presented here suggest other issues that should be further addressed in future TOS studies. The TOS cohort may have fewer risk factors such as smoking 9 and alcohol consumption 9 or elevated blood lipids. 4 Also, since one mechanism for the development of TOS has been hypothesized to be through the immune system, could a hyperimmune state result in a diminished cancer incidence in this cohort? Differences in these factors could account for some of the differences in cardiovascular and cancer mortality in the TOS cohort. And lastly, many cohort members have received certain economic benefits as a result of their illness, which may have led to an increase in overall socioeconomic status and therefore a decrease in mortality.
The natural history of TOS is that of a long-term, chronic debilitating illness, but one which, on the basis of our data, is not a cause of overall additional mortality. However, thousands of TOS patients still suffer greatly from chronic pain and disability, and certain groups, such as women aged <40 years, are experiencing higher than expected rates of death. Continued study of the causes of death with closer scrutiny of death certificates and medical records may shed additional light on this topic. Until studies to validate certified causes of death are concluded, we cannot draw conclusions about the natural history of TOS on the basis of death certificates which list TOS as the underlying cause of death.
